Pharmacogenetic tests can be found in the form of general panels dedicated to different medical specialties.
All tests include a clinical care tool that helps identify potential drug-drug and / or drug-gene interactions.
Pharmacogenetic Standard Panel
CYP3A4, CYP3A5, CYP2C9, CYP2C19 si CYP2D6
Pharmacogenetic Comprehensive Panel
ADRA2A, CYP1A2, CYP3A4, CYP3A5, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP4F2 / VKORC1, COMT, DPYD, F2 (Factor II), F5 (Factor V) Leiden, GRI, IFNL3 (IL28B), MTHFR, NAT2, OPRM1, SLCO1B1, TPMT, UGT1A1
Pharmacogenetic Cardiology Panel
CYP3A4, CYP3A5, CYP2C9, CYP2C19, CYP2D6, APOE, F2 (Factor II), F5 (Factor V) Leiden, MTHFR, SLCO1B1 (statins), VKORC1 (warfin)
Pharmacogenetic Psychiatry Panel
CYP3A4, CYP3A5, CYP2C9, CYP2C19, CYP2D6, GRIK4 (citalopram), HTR2A (SSRIs, non-SSRIs), HTR2C (antipsychotics)
The analysis of the results is based on the information provided by the pharmacogenetic testing (PGx), combined with the analysis of the clinical pharmacist and the scientific data approved by the regulatory agencies in the field.
The prescribing physician benefits from a specialized clinical support platform, called YouScript. Based on current clinical evidence, YouScript is the only software that provides a biological basis for understanding why interactions occur and then informs about safer and more effective alternatives for each individual patient.